Dr. Glenn is the Joseph D. Grant Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University, and Director of ViRx@Stanford, the Stanford Biosecurity and Pandemic Preparedness Initiative. He has over 30 years of experience in basic science and clinical development. With demonstrated experience in molecular virology and the translation of that knowledge into novel antiviral therapies, his inventions and efforts have helped found new companies focused on developing drugs from technologies developed in his lab, with six different drugs currently in development (two of which are in phase III) as a result. Dr. Glenn is also the PI on a U19  Antiviral Drug Discovery (AViDD) Center, SyneRx. He received his A.B. degree, summa cum laude with a double major in biochemistry and French civilization from U.C. Berkeley. He received his M.D. and Ph.D. in biochemistry and biophysics from the U.C.S.F. MSTP program.